Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axonal-Biostatem is a leading French Contract Research Organization (CRO) providing comprehensive clinical and epidemiological research services. Founded in 1989, the company specializes in project management, data management, biostatistics, and medical writing for the pharmaceutical, biotechnology, and medical device sectors. Axonal-Biostatem is particularly recognized for its expertise in real-world evidence (RWE), non-interventional studies, and early access programs. In August 2023, the company was acquired by Docaposte, the digital subsidiary of La Poste Group, and subsequently merged with Heva in 2024 to operate under the Heva brand. Headquartered in Nanterre, France, the company continues to support global and local clients in evaluating innovative therapies and medical technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Axonal-Biostatem.